Research
Hormonal
Novel medications such as GLP-1 agonists have demonstrated sustained weight loss in patients with obesity.
Practitioners can consider GLP-1 agonists as a treatment option for obesity.
StrongSupportsmedium confidence
Novel medications such as GLP-1 agonists have demonstrated sustained weight loss in patients with obesity.
Why this rating
The claim is based on recent findings discussed in the abstract.
Source
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension
Maria Irene Barillas-Lara et al. · Current Opinion in Cardiology · 2023
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →